These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 23726275)

  • 1. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
    Hou Z; Nie C; Si Z; Ma Y
    Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
    Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
    Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
    Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
    J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells.
    Hopfner U; Maan ZN; Hu MS; Aitzetmüller MM; Zaussinger M; Kirsch M; Machens HG; Duscher D
    J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1738-1746. PubMed ID: 32418841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
    Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y
    ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway.
    Zeng Z; Huang WD; Gao Q; Su ML; Yang YF; Liu ZC; Zhu BH
    Int J Mol Med; 2015 Sep; 36(3):685-97. PubMed ID: 26202335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice.
    Zhang EY; Gao B; Shi HL; Huang LF; Yang L; Wu XJ; Wang ZT
    Exp Mol Med; 2017 Oct; 49(10):e387. PubMed ID: 29075038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.
    Wang C; Cai Y; Zhang Y; Xiong Z; Li G; Cui L
    PLoS One; 2014; 9(6):e100818. PubMed ID: 24963878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecithin-based deferoxamine nanoparticles accelerated cutaneous wound healing in diabetic rats.
    Qayoom A; Aneesha VA; Anagha S; Dar JA; Kumar P; Kumar D
    Eur J Pharmacol; 2019 Sep; 858():172478. PubMed ID: 31228457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
    Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
    Wound Repair Regen; 2019 Jul; 27(4):324-334. PubMed ID: 30817065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats.
    Xie P; Yang L; Talaiti A; Wu JJ; Yu J; Yu T; Wang HY; Huang B; Wu Q; Maimaitili Y; Wang J; Ma HP; Yang YN; Zheng H
    Acta Physiol (Oxf); 2017 Oct; 221(2):98-114. PubMed ID: 28316125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
    Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
    Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues.
    Thangarajah H; Yao D; Chang EI; Shi Y; Jazayeri L; Vial IN; Galiano RD; Du XL; Grogan R; Galvez MG; Januszyk M; Brownlee M; Gurtner GC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13505-10. PubMed ID: 19666581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
    Ram M; Singh V; Kumawat S; Kumar D; Lingaraju MC; Uttam Singh T; Rahal A; Kumar Tandan S; Kumar D
    Eur J Pharmacol; 2015 Oct; 764():9-21. PubMed ID: 26101070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal deferoxamine prevents pressure-induced diabetic ulcers.
    Duscher D; Neofytou E; Wong VW; Maan ZN; Rennert RC; Inayathullah M; Januszyk M; Rodrigues M; Malkovskiy AV; Whitmore AJ; Walmsley GG; Galvez MG; Whittam AJ; Brownlee M; Rajadas J; Gurtner GC
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):94-9. PubMed ID: 25535360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides.
    Dallas A; Trotsyuk A; Ilves H; Bonham CA; Rodrigues M; Engel K; Barrera JA; Kosaric N; Stern-Buchbinder ZA; White A; Mandell KJ; Hammond PT; Mansbridge J; Jayasena S; Gurtner GC; Johnston BH
    Tissue Eng Part A; 2019 Jan; 25(1-2):44-54. PubMed ID: 29644938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis.
    Huang X; Liang P; Jiang B; Zhang P; Yu W; Duan M; Guo L; Cui X; Huang M; Huang X
    Life Sci; 2020 Oct; 259():118246. PubMed ID: 32791151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of glycated protein and DFO mimicked hypoxia in cellular responses of HUVECs.
    Bala K; Gohil NK
    Mol Biosyst; 2012 Oct; 8(10):2657-63. PubMed ID: 22790884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.